Friday, November 20 2026
MONETABRIEF β Morison, a unit of Sri Lanka's Hemas said the group has started marketing pharmaceuticals made in the country in Cambodia.
Morison had secured thirteen product registrations in Cambodia, with approval sought for another seven.
Morison said it was as the first Sri Lankan pharma manufacturer to start medical marketing operations in a foreign country with its own team of medical representatives.
"For the past 70 years, Hemas has been importing pharmaceuticals to Sri Lanka," Murtaza Esufally, Chairman of the Hemas Healthcare Cluster, said in a statement.
"Therefore, witnessing Hemas-manufactured pharmaceuticals being exported to another country for the first time is a particularly proud moment for us.
"It marks a significant milestone in our journey and reflects our ambition to take Sri Lankan pharmaceutical manufacturing beyond our shores."
The Cambodian operation is headed by Prabuddha Walpita as country manager who was previously Senior Manager Commercial at Morison.
Having joined the company in 2016, Walpita said he saw the firm move from being known for Morisonβs Gripe Mixture and Morisonβs Lacto Calamine to a branded generics pharma manufacturer.
With a population of 18 million people, Cambodia has a market of valued at nearly 350 million US dollars and imports 95 percent of its pharmaceuticals.
The country operates in line with WHO GMP guidelines, making it a natural first destination for medicines manufactured to international standards in Sri Lanka, Hemas said.
The first shipment had three brands marketed under the brands of EmpaMor (Empagliflozin Tablets 10 mg and 25 mg), BisoMor (Bisoprolol Tablets BP 2.5 mg and 5 mg), and RivoMor (Rivaroxaban Tablets 10 mg and 20 mg).
Morison entered the generics market four years ago. In Diabetes medicine, EmpaMor has become the highest-selling Empagliflozin brand, within two years of its launch, the firm said.
Morison has since expanded into cardiovascular products, supported by its new pharmaceutical manufacturing facility in Homagama. (Colombo/Nov19/2026)
| 3 month bill | 9.26% | 1bp β² |
| 12-m bill | 9.95% | 2bp - |
| Gold (Ounce) | $4015 | - βΌ |
Comments
Be the first person to comment and join the debate